S&P 500   3,325.54 (+0.11%)
DOW   29,160.09 (-0.09%)
QQQ   224.59 (+0.32%)
AAPL   319.23 (+0.48%)
FB   219.76 (-0.70%)
MSFT   166.72 (+0.62%)
GOOGL   1,484.69 (+0.04%)
AMZN   1,884.58 (-0.15%)
CGC   24.56 (+1.82%)
BABA   219.13 (-1.46%)
MU   59.20 (+0.05%)
GE   11.77 (+3.52%)
TSLA   572.20 (+0.46%)
AMD   51.71 (+0.54%)
T   38.63 (-1.05%)
F   9.14 (-0.22%)
NFLX   349.60 (+7.24%)
BAC   34.12 (-0.70%)
DIS   142.20 (-1.26%)
GILD   63.94 (+0.80%)
S&P 500   3,325.54 (+0.11%)
DOW   29,160.09 (-0.09%)
QQQ   224.59 (+0.32%)
AAPL   319.23 (+0.48%)
FB   219.76 (-0.70%)
MSFT   166.72 (+0.62%)
GOOGL   1,484.69 (+0.04%)
AMZN   1,884.58 (-0.15%)
CGC   24.56 (+1.82%)
BABA   219.13 (-1.46%)
MU   59.20 (+0.05%)
GE   11.77 (+3.52%)
TSLA   572.20 (+0.46%)
AMD   51.71 (+0.54%)
T   38.63 (-1.05%)
F   9.14 (-0.22%)
NFLX   349.60 (+7.24%)
BAC   34.12 (-0.70%)
DIS   142.20 (-1.26%)
GILD   63.94 (+0.80%)
S&P 500   3,325.54 (+0.11%)
DOW   29,160.09 (-0.09%)
QQQ   224.59 (+0.32%)
AAPL   319.23 (+0.48%)
FB   219.76 (-0.70%)
MSFT   166.72 (+0.62%)
GOOGL   1,484.69 (+0.04%)
AMZN   1,884.58 (-0.15%)
CGC   24.56 (+1.82%)
BABA   219.13 (-1.46%)
MU   59.20 (+0.05%)
GE   11.77 (+3.52%)
TSLA   572.20 (+0.46%)
AMD   51.71 (+0.54%)
T   38.63 (-1.05%)
F   9.14 (-0.22%)
NFLX   349.60 (+7.24%)
BAC   34.12 (-0.70%)
DIS   142.20 (-1.26%)
GILD   63.94 (+0.80%)
S&P 500   3,325.54 (+0.11%)
DOW   29,160.09 (-0.09%)
QQQ   224.59 (+0.32%)
AAPL   319.23 (+0.48%)
FB   219.76 (-0.70%)
MSFT   166.72 (+0.62%)
GOOGL   1,484.69 (+0.04%)
AMZN   1,884.58 (-0.15%)
CGC   24.56 (+1.82%)
BABA   219.13 (-1.46%)
MU   59.20 (+0.05%)
GE   11.77 (+3.52%)
TSLA   572.20 (+0.46%)
AMD   51.71 (+0.54%)
T   38.63 (-1.05%)
F   9.14 (-0.22%)
NFLX   349.60 (+7.24%)
BAC   34.12 (-0.70%)
DIS   142.20 (-1.26%)
GILD   63.94 (+0.80%)
Log in
(Ad)
If you're looking to potentially make 1,000% in gains, then you NEED this biotech stock. This company discovered a medical breakthrough that may end heart attacks FOREVER! Estimated annual sales are $60 billion. The FDA has all but said it's going to approve the drug. Once that happens, the stock price could double overnight. But you must be onboard BEFORE FDA approval.

OTCMKTS:FSRVU - FinServ Acquisition Stock Price, Forecast & News

$10.45
0.00 (0.00 %)
(As of 01/23/2020 04:00 PM ET)
Today's Range
$10.45
Now: $10.45
$10.45
50-Day Range N/A
52-Week Range
$10.05
Now: $10.45
$10.64
VolumeN/A
Average Volume7,370 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Finserv Acquisition Corp. intends to acquire assets and businesses through a merger, capital stock exchange, stock purchase, reorganization, or business combination. The company was founded in 2019 and is based in New York, New York.

Industry, Sector and Symbol

Industry Shell Companies
Sub-IndustryN/A
SectorFinancial Services
Current SymbolOTCMKTS:FSRVU
CUSIPN/A
CIKN/A
WebN/A
Phone646-965-8218

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive FSRVU News and Ratings via Email

Sign-up to receive the latest news and ratings for FSRVU and its competitors with MarketBeat's FREE daily newsletter.


(Ad)

A U.S. congressional committee passed important legislation that enables each state to set its own policies around cannabis… This bill also allows states to expunge federal marijuana convictions and arrests. This will likely lead to federal legalization sooner than expected. Get in early and you just might be the next 'Marijuana Millionaire'...

FinServ Acquisition (OTCMKTS:FSRVU) Frequently Asked Questions

What is FinServ Acquisition's stock symbol?

FinServ Acquisition trades on the OTCMKTS under the ticker symbol "FSRVU."

Has FinServ Acquisition been receiving favorable news coverage?

News stories about FSRVU stock have trended extremely negative this week, according to InfoTrie Sentiment Analysis. The research firm ranks the sentiment of media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. FinServ Acquisition earned a daily sentiment score of -5.0 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the next few days. View News Stories for FinServ Acquisition.

Who are some of FinServ Acquisition's key competitors?

Who are FinServ Acquisition's key executives?

FinServ Acquisition's management team includes the folowing people:
  • Mr. Lee Einbinder, CEO & Director (Age 59)
  • Mr. Howard Alan Kurz, Pres, CFO & Director (Age 62)

When does the company's lock-up period expire?

FinServ Acquisition's lock-up period expires on Wednesday, April 29th. FinServ Acquisition had issued 22,000,000 shares in its initial public offering on November 1st. The total size of the offering was $220,000,000 based on an initial share price of $10.00. After the expiration of the company's lock-up period, restrictions preventing major shareholders and company insiders from selling shares in the company will be lifted.

How do I buy shares of FinServ Acquisition?

Shares of FSRVU can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is FinServ Acquisition's stock price today?

One share of FSRVU stock can currently be purchased for approximately $10.45.

How can I contact FinServ Acquisition?

The company can be reached via phone at 646-965-8218.


MarketBeat Community Rating for FinServ Acquisition (OTCMKTS FSRVU)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  4 (Vote Outperform)
Underperform Votes:  5 (Vote Underperform)
Total Votes:  9
MarketBeat's community ratings are surveys of what our community members think about FinServ Acquisition and other stocks. Vote "Outperform" if you believe FSRVU will outperform the S&P 500 over the long term. Vote "Underperform" if you believe FSRVU will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/23/2020 by MarketBeat.com Staff

Featured Article: What is a capital gain?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel